BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 8954321)

  • 1. Inhibition of human complement-dependent cell lysis by bovine aortic endothelial cells transfected with membrane-bound complement-regulatory factor (DAF and HRF20) gene using a retroviral vector.
    Hayashi S; Isobe K; Emi N; Yokoyama I; Okada H; Nakashima I; Takagi H
    Eur Surg Res; 1996; 28(6):440-6. PubMed ID: 8954321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory effect of double transfection to xenoendothelial cells using both decay accelerating factor and homologous restriction factor 20 genes on complement dependent cytolysis.
    Hayashi S; Emi N; Isobe K; Yokoyama I; Okada H; Takagi H
    J Surg Res; 1996 Feb; 61(1):165-9. PubMed ID: 8769961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C5b-8 step lysis of swine endothelial cells by human complement and functional feature of transfected CD59.
    Miyagawa S; Mikata S; Shirakura R; Matsuda H; Nagasawa S; Terados A; Hatanaka M; Matsumoto M; Seya T
    Scand J Immunol; 1996 Apr; 43(4):361-6. PubMed ID: 8668913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of the complement regulatory proteins CD21, CD55 and CD59 on Burkitt lymphoma lines: their role in sensitivity to human serum-mediated lysis.
    Kuraya M; Yefenof E; Klein G; Klein E
    Eur J Immunol; 1992 Jul; 22(7):1871-6. PubMed ID: 1378022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection of xeno-hepatocytes from complement-mediated cytolysis by transduction with homologous restriction factor 20 gene using retroviral vector.
    Hayashi S; Isobe K; Emi N; Okada H; Yokoyama I; Takagi H
    Eur Surg Res; 1998; 30(3):161-7. PubMed ID: 9627212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of species-specific complement-mediated cytolysis in xenoendothelial cells transfected with GPI-anchored complement regulatory factor (DAF, HRF20) gene using retroviral vector: comparison between single (DAF or HRF20) and double (DAF and HRF20) transfected xenoendothelial cells.
    Hayashi S; Isobe K; Emi N; Yokoyama I; Takagi H
    Transplant Proc; 1994 Jun; 26(3):1243-4. PubMed ID: 7518119
    [No Abstract]   [Full Text] [Related]  

  • 7. Protection of xenogeneic cells from human complement-mediated lysis by the expression of human DAF, CD59 and MCP.
    Huang J; Gou D; Zhen C; Jiang D; Mao X; Li W; Chen S; Cai C
    FEMS Immunol Med Microbiol; 2001 Oct; 31(3):203-9. PubMed ID: 11720816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cooperation between human DAF and CD59 in protecting cells from human complement-mediated lysis.
    Xu L; Wu W; Zhao Z; Shao H; Liu W; Liu H; Li W
    J Biochem Mol Biol; 2006 Nov; 39(6):743-8. PubMed ID: 17129411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effects of different combinations of human MCP, DAF, and CD59 on complement-dependent cytolysis in NIH 3T3 cells.
    Yang X; Deng J; Jiang Z; Liao DJ; Jiang H
    Exp Clin Transplant; 2012 Feb; 10(1):49-54. PubMed ID: 22309420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Species-specific restriction of complement by HRF20 (CD59) generated by cDNA transfection.
    Takizawa H; Takahashi K; Murakami T; Okada N; Okada H
    Eur J Immunol; 1992 Jul; 22(7):1943-6. PubMed ID: 1378024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection of rat endothelial cells from primate complement-mediated lysis by expression of human CD59 and/or decay-accelerating factor.
    Charreau B; Cassard A; Tesson L; Le Mauff B; Navenot JM; Blanchard D; Lublin D; Soulillou JP; Anegon I
    Transplantation; 1994 Dec; 58(11):1222-9. PubMed ID: 7527603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crry, but not CD59 and DAF, is indispensable for murine erythrocyte protection in vivo from spontaneous complement attack.
    Miwa T; Zhou L; Hilliard B; Molina H; Song WC
    Blood; 2002 May; 99(10):3707-16. PubMed ID: 11986227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Localization of the complement regulatory proteins in the normal human kidney.
    Ichida S; Yuzawa Y; Okada H; Yoshioka K; Matsuo S
    Kidney Int; 1994 Jul; 46(1):89-96. PubMed ID: 7523758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection of xenogeneic cardiac endothelium from human complement by expression of CD59 or DAF in transgenic mice.
    Byrne GW; McCurry KR; Kagan D; Quinn C; Martin MJ; Platt JL; Logan JS
    Transplantation; 1995 Nov; 60(10):1149-56. PubMed ID: 7482724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of complement regulatory proteins CR1, DAF, MCP and CD59 in haematological malignancies.
    Guc D; Canpinar H; Kucukaksu C; Kansu E
    Eur J Haematol; 2000 Jan; 64(1):3-9. PubMed ID: 10680700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delta-short consensus repeat 4-decay accelerating factor (DAF: CD55) inhibits complement-mediated cytolysis but not NK cell-mediated cytolysis.
    Miyagawa S; Kubo T; Matsunami K; Kusama T; Beppu K; Nozaki H; Moritan T; Ahn C; Kim JY; Fukuta D; Shirakura R
    J Immunol; 2004 Sep; 173(6):3945-52. PubMed ID: 15356143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Test for ability of decay-accelerating factor (DAF, CD55) and CD59 to alleviate complement-mediated damage of xeno-erythrocytes.
    Miyagawa S; Shirakura R; Matsumiya G; Nakata S; Matsuda H; Hatanaka M; Matsumoto M; Kitamura H; Seya T
    Scand J Immunol; 1993 Jul; 38(1):37-44. PubMed ID: 7687071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of transfected complement regulatory proteins, MCP, DAF, and MCP/DAE hybrid, on complement-mediated swine endothelial cell lysis.
    Miyagawa S; Shirakura R; Iwata K; Nakata S; Matsumiya G; Izutani H; Matsuda H; Terado A; Matsumoto M; Nagasawa S
    Transplantation; 1994 Oct; 58(7):834-40. PubMed ID: 7524206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced expression of decay accelerating factor and CD59/homologous restriction factor 20 on the colonic epithelium of ulcerative colitis.
    Uesu T; Mizuno M; Inoue H; Tomoda J; Tsuji T
    Lab Invest; 1995 May; 72(5):587-91. PubMed ID: 7538183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relative roles of decay-accelerating factor, membrane cofactor protein, and CD59 in the protection of human endothelial cells against complement-mediated lysis.
    Brooimans RA; van Wieringen PA; van Es LA; Daha MR
    Eur J Immunol; 1992 Dec; 22(12):3135-40. PubMed ID: 1280224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.